Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo

American Journal of Psychiatry

Volumn 155, Issue 11, 1998, Pages 1570-1577

  Michelson, David ^a   Lydiard, R Bruce ^b   Pollack, Mark H ^b   Tamura, Roy N ^b   Hoog, Sharon L ^b   Tepner, Rosalinda ^b   Demitrack, Mark A ^b   Tollefson, Gary D ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031731533     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.11.1570     Document Type: Article

References (25)

1. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL: Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46:984-992
2. Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, Fyer AJ: Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry 1997; 154:766-772
3. Leon AC, Shear MK, Portera L, Klerman GL: The relationship of symptomatology to impairment in patients with panic disorder. J Psychiatr Res 1993; 27:361-367
4. Johnson J, Weissman MM, Klerman GL: Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry 1990; 47:805-808
5. Krystal JH, Woods SW, Hill CL, Charney DS: Characteristics of panic attack subtypes: assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks. Compr Psychiatry 1991; 32:474-480
6. Bandelow B, Hajak G, Holzrichter S, Kunert HJ, Ruther E: Assessing the efficacy of treatments for panic disorder and agoraphobia, I: methodological problems. Int Clin Psychopharmacol 1995; 10:83-93
7. Shear MK, Maser JD: Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994; 51:346-354
8. Grove G, Coplan JD, Hollander E: The neuroanatomy of 5-HT dysregulation and panic disorder. J Neuropsychiatry Clin Neurosci 1997; 9:198-207
9. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM: Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 1997; 54:643-648
10. Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T: The effect of citalopram in panic disorder. Br J Psychiatry 1997; 170:549-553
11. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167:374-379
12. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1986
13. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
14. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA: Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154: 1571-1575
15. Riskind JH, Beck AT, Brown G, Steer RA: Taking the measure of anxiety and depression: validity of the reconstructed Hamilton scales. J Nerv Ment Dis 1987; 175:474-479
16. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
17. Sheehan DV: The Anxiety Disease. New York, Charles Scribner & Sons, 1983
18. Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF: Fluoxetine in panic disorder. J Clin Psychopharmacol 1990; 10:119-121
19. Gorman JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas RB, Fyer MR, Davies SO, Klein DF: An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987; 7:329-332
20. Margraf J, Taylor B, Ehlers A, Roth WT, Agras WS: Panic attacks in the natural environment. J Nerv Ment Dis 1987; 175: 558-565
21. Tollefson GD, Rampey AH Jr, Potvin JH, Jenike MA, Rush A, Kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA: A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994; 51:559-567
22. Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992; 49:139-147
23. Rosenbaum JF, Pollack MH, Pollock RA: Clinical issues in the long-term treatment of panic disorder. J Clin Psychiatry 1996; 57(suppl 10):44-50
24. Judge R, Burnham DB, Steiner MX, Gergel IP, Oakes R, Bailer DC, Wheadon DE: Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: a double-blind study (poster 85), in Proceedings of the Xth World Congress of Psychiatry, Madrid. New York, World Psychiatric Association, 1996, p 252
25. Giesecke ME: Overcoming hypersensitivity to fluoxetine in a patient with panic disorder (letter). Am J Psychiatry 1990; 147:532-533